Portal de Periódicos da CAPES

Successful control of bleeding during supracondylar amputation caused by severe compartment syndrome in patient with haemophilia A and high titre of inhibitor

2009; Wiley; Volume: 15; Issue: 2 Linguagem: Inglês

10.1111/j.1365-2516.2008.01943.x

1365-2516

Natalija Rajić, Aleksandar Savić, Svetlana Popović, Ivana Urošević, Ivana Savić,

Chronic Myeloid Leukemia Treatments

HaemophiliaVolume 15, Issue 2 p. 601-602 Successful control of bleeding during supracondylar amputation caused by severe compartment syndrome in patient with haemophilia A and high titre of inhibitor N. RAJIC, N. RAJIC Clinic of Haematology, Clinical Centre of Vojvodina, Novi Sad, SerbiaSearch for more papers by this authorA. SAVIC, A. SAVIC Clinic of Haematology, Clinical Centre of Vojvodina, Novi Sad, SerbiaSearch for more papers by this authorS. POPOVIC, S. POPOVIC Clinic of Haematology, Clinical Centre of Vojvodina, Novi Sad, SerbiaSearch for more papers by this authorI. UROSEVIC, I. UROSEVIC Clinic of Haematology, Clinical Centre of Vojvodina, Novi Sad, SerbiaSearch for more papers by this authorI. SAVIC, I. SAVIC Clinic of Haematology, Clinical Centre of Vojvodina, Novi Sad, SerbiaSearch for more papers by this author N. RAJIC, N. RAJIC Clinic of Haematology, Clinical Centre of Vojvodina, Novi Sad, SerbiaSearch for more papers by this authorA. SAVIC, A. SAVIC Clinic of Haematology, Clinical Centre of Vojvodina, Novi Sad, SerbiaSearch for more papers by this authorS. POPOVIC, S. POPOVIC Clinic of Haematology, Clinical Centre of Vojvodina, Novi Sad, SerbiaSearch for more papers by this authorI. UROSEVIC, I. UROSEVIC Clinic of Haematology, Clinical Centre of Vojvodina, Novi Sad, SerbiaSearch for more papers by this authorI. SAVIC, I. SAVIC Clinic of Haematology, Clinical Centre of Vojvodina, Novi Sad, SerbiaSearch for more papers by this author First published: 23 March 2009 https://doi.org/10.1111/j.1365-2516.2008.01943.xCitations: 8 Nebojsa Rajic, MD, Clinic of Haematology, Clinical Centre of Vojvodina, Novi Sad 21000, Serbia.Tel.: +381 21 484 3424; fax: +381 21 525081; e-mail: [email protected] Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1 Hay RMC, Brown S, Collins PW et al. The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia centre Doctors Organisation. Br J Haematol 2006; 133: 591–605. 10.1111/j.1365-2141.2006.06087.x CASPubMedWeb of Science®Google Scholar 2 Obergfell A, Auvinen MK, Mathew P. Recombinant activated factor VII for haemophilia patients with inhibitors undergoing orthopaedic surgery: a review of the literature. Haemophilia 2008; 14: 233–41. 10.1111/j.1365-2516.2007.01617.x CASPubMedWeb of Science®Google Scholar 3 Ludlam CA, Smith MP, Morfini M et al. A prospective study of recombinant activated factor VII administered by continuous infusion to inhibitor patients undergoing elective major orthopaedic surgery: a pharmacokinetic and efficacy evaluation. Br J Haematol 2003; 120: 808–13. 10.1046/j.1365-2141.2003.04173.x CASPubMedWeb of Science®Google Scholar 4 Kraut EH, Aledort LM, Arkin S et al. Surgical interventions in a cohort of patients with haemophilia A and inhibitors: an experiential retrospective chart review. Haemophilia 2007; 13: 508–17. 10.1111/j.1365-2516.2007.01523.x CASPubMedWeb of Science®Google Scholar 5 Hayashi T, Tanaka I, Shima M et al. Unresponsivenes to factor VIII inhibitor bypassing agents during haemostatic treatment for life-threatening massive bleeding in a patient with haemophilia A and a high responding inhibitor. Haemophilia 2004; 10: 397–400. 10.1111/j.1365-2516.2004.00924.x CASPubMedWeb of Science®Google Scholar Citing Literature Volume15, Issue2March 2009Pages 601-602 ReferencesRelatedInformation